The mutational landscape differed by breast cancer subtype with common mutations detected in patients with advanced TNBC (n = 30) being BRCA1/2 (57%, 16/30), TP53 (40%, 12/30), and PIK3CA (13%, 4/30). Here, TP53 is linked to breast carcinoma.